These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 10872100

  • 1. Dissolution of omeprazole from delayed-release solid oral dosage forms.
    Farinha A, Bica A, Martins JM, Pais JP.
    Drug Dev Ind Pharm; 2000 Jul; 26(7):785-90. PubMed ID: 10872100
    [Abstract] [Full Text] [Related]

  • 2. Stability of capsules containing omeprazole in enteric coated pellets.
    Palummo M, Cingolani A, Dall L, Volonté MG.
    Boll Chim Farm; 2000 Jul; 139(3):124-8. PubMed ID: 10961022
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dissolution test for liquid formulations of omeprazole enteric-coated products.
    Jang HJ, Kang BC, Shin WG, Lee S.
    Ann Pharmacother; 2003 Jan; 37(1):150-1. PubMed ID: 12503954
    [No Abstract] [Full Text] [Related]

  • 5. Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.
    He W, Fan LF, Du Q, Xiang B, Li CL, Bai M, Chang YZ, Cao DY.
    Chem Pharm Bull (Tokyo); 2009 Feb; 57(2):122-8. PubMed ID: 19182399
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of a bionic system for the simultaneous prediction of the release/absorption characteristics of enteric-coated formulations.
    Liu W, He X, Li Z, Gao X, Ma Y, Xun M, Liu C.
    Pharm Res; 2013 Feb; 30(2):596-605. PubMed ID: 23135820
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development and evaluation of an omeprazole-based delayed-release liquid oral dosage form.
    Ronchi F, Sereno A, Paide M, Sacré P, Guillaume G, Stéphenne V, Goole J, Amighi K.
    Int J Pharm; 2019 Aug 15; 567():118416. PubMed ID: 31175991
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro study on capsule formulations of omeprazole containing enteric coated granules.
    Pandey VP, Phanindrudu A, Manavalan R, Livingston J.
    Boll Chim Farm; 2002 Aug 15; 141(6):419-22. PubMed ID: 12577509
    [Abstract] [Full Text] [Related]

  • 16. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB, Fort JG, Zhang Y.
    Aliment Pharmacol Ther; 2013 Jul 15; 38(1):62-71. PubMed ID: 23692061
    [Abstract] [Full Text] [Related]

  • 17. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
    Andrews FM, Doherty TJ, Blackford JT, Nadeau JA, Saxton AM.
    Am J Vet Res; 1999 Aug 15; 60(8):929-31. PubMed ID: 10451198
    [Abstract] [Full Text] [Related]

  • 18. Bioequivalence evaluation of two omeprazole enteric-coated formulations in humans.
    Farinha A, Bica A, Pais JP, Toscano MC, Tavares P.
    Eur J Pharm Sci; 1999 Mar 15; 7(4):311-5. PubMed ID: 9971914
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling.
    Yang R, Lin Y, Chen K, Huang J, Yang S, Yao A, Yang X, Lei D, Xiao J, Yang G, Pei Q.
    AAPS J; 2024 Jul 12; 26(4):82. PubMed ID: 38997548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.